Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEXIDARTINIB vs VILOXAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PEXIDARTINIB vs VILOXAZINE: Safety Overview

Metric PEXIDARTINIB VILOXAZINE
Total FAERS Reports 970 853
Deaths Reported 17 9
Death Rate 1.8% 1.1%
Hospitalizations 91 59
Average Patient Age 44.9 yrs 21.6 yrs
% Female Patients 63.4% 47.2%
FDA Approval Date Aug 2, 2019 Apr 2, 2021
Manufacturer Daiichi Sankyo Inc. Supernus Pharmaceuticals, Inc
Route ORAL ORAL
Marketing Status Discontinued Prescription